Inventor · disambiguated record
Mark Brönstrup
Also filed as: BROENSTRUP MARK · BRÖNSTRUP Mark
5 granted patents·2 pending applications·3 citations·filing 2001–2022
64Inventor score
Files withHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH4AVENTIS PHARMA GMBH2SANOFI AVENTIS DEUTSCHLAND1
Top patents by PatentIndex Score
7 records- 0165US6596694B2Caloporoside derivatives, methods of their preparation and useAVENTIS PHARMA GMBH·Filed 2002·Granted Jul 22, 2003·3 cites·17 claims
- 0249US11331371B2Labyrinthopeptins as anti-viral agentsHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2019·Granted May 17, 2022·0 cites·13 claims
- 0349US2024376084A1Inhibitors of alpha-hemolysin of staphylococcus aureusHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2022·Application pending·0 cites
- 0448US7112608B2Hydroxyphenylundecane, a process for their production and their useSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Sep 26, 2006·0 cites·10 claims
- 0541US2019046604A1Labyrinthopeptins as anti-viral agentsHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2016·Application pending·0 cites
- 0640US6930130B2Citrullimycines, a process for their production and their use as pharmaceuticalsAVENTIS PHARMA GMBH·Filed 2001·Granted Aug 16, 2005·0 cites·21 claims
- 0727US11034648B2Cystobactamide derivativesHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2018·Granted Jun 15, 2021·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Mark Brönstrup files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →